Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | GCC19CART |
| Trade Name | |
| Synonyms | GCC19-CART|GCC19 CART |
| Drug Descriptions |
GCC19CART is a chimeric antigen receptor (CAR) T-cell therapy comprising T-lymphocytes that target guanylate cyclase-C (GUY2C) and CD19, potentially resulting in antitumor activity (Cancer Res (2023) 83 (7_Supplement): 1130). |
| DrugClasses | CD19 Immune Cell Therapy 72 |
| CAS Registry Number | NA |
| NCIT ID | C187317 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| GCC19CART | GCC19CART | 0 | 1 |